- Published on
Pathology - Acute Bacterial Pneumonia
Lobar pneumonia is mostly caused by the bacterium Streptococcus pneumoniae, which is responsible for 90%-95% of cases.
The causative agents of bronchopneumonia include Staphylococcus aureus, Haemophilus influenza, Klebsiella, and Strentococcus pyogenes.
Lobar pneumonia is characterized by the presence of intra-alveolar exudate, which causes consolidation of the affected area. This process occurs in four distinct stages.
(1) Congestion: Severe accumulation of red fluid in the lungs, specifically in the tiny air sacs called alveoli; (2) Red hepatization: Presence of red blood cells, fibrin, and neutrophils within the alveoli; (3) Gray hepatization: Presence of fibrin and neutrophils within the alveoli.
[4) resolution: The exudate within the alveoli is absorbed back into the body.]
Bronchopneumonia is a type of pneumonia that affects the bronchi, which are the air passages in the lungs. Otten exhibits bilateral and multilobar involvement, with neutrophil exudate extending from the bronchi and bronchioles into the adjacent alveoli.
Symptoms include general discomfort, elevated body temperature, difficulty breathing, and a cough that produces mucus.
The physical examination reveals the presence of bronchial breath sounds and rales upon auscultation, as well as a dullness to percussion over the afflicted parts of the lungs.
Possible complications encompass abscess formation, empyema development, or sepsis occurrence.
Imaging: A chest X-ray reveals a dense area in the lung indicating lobar pneumonia, or scattered areas of opacity suggesting bronchopneumonia.
Treatment options include the administration of antibiotics and providing breathing support.
Hospital-acquired pneumonias can result from the presence of gram-negative pathogens such as Klebsiella, Escherichia coli, and Pseudomonas, as well as gram-positive organisms such S aureus. These infections have the potential to be life-threatening.
Lobar pneumonia is mostly caused by the bacterium Streptococcus pneumoniae, which is responsible for 90%-95% of cases.
The causative agents of bronchopneumonia include Staphylococcus aureus, Haemophilus influenza, Klebsiella, and Strentococcus pyogenes.
Lobar pneumonia is characterized by the presence of intra-alveolar exudate, which causes consolidation of the affected area. This process occurs in four distinct stages.
(1) Congestion: Severe accumulation of red fluid in the lungs, specifically in the tiny air sacs called alveoli; (2) Red hepatization: Presence of red blood cells, fibrin, and neutrophils within the alveoli; (3) Gray hepatization: Presence of fibrin and neutrophils within the alveoli.
[4) resolution: The exudate within the alveoli is absorbed back into the body.]
Bronchopneumonia is a type of pneumonia that affects the bronchi, which are the air passages in the lungs. Otten exhibits bilateral and multilobar involvement, with neutrophil exudate extending from the bronchi and bronchioles into the adjacent alveoli.
Symptoms include general discomfort, elevated body temperature, difficulty breathing, and a cough that produces mucus.
The physical examination reveals the presence of bronchial breath sounds and rales upon auscultation, as well as a dullness to percussion over the afflicted parts of the lungs.
Possible complications encompass abscess formation, empyema development, or sepsis occurrence.
Imaging: A chest X-ray reveals a dense area in the lung indicating lobar pneumonia, or scattered areas of opacity suggesting bronchopneumonia.
Treatment options include the administration of antibiotics and providing breathing support.
Hospital-acquired pneumonias can result from the presence of gram-negative pathogens such as Klebsiella, Escherichia coli, and Pseudomonas, as well as gram-positive organisms such S aureus. These infections have the potential to be life-threatening.
- Published on
Pathology - Cardiac Neoplasms ( Atrial Myxoma and Rhabdomyoma)
Myxomas: The etiology of this condition is still unknown, although around 10% of cases are attributed to an autosomal dominant trait. It is typically observed in adults.
Rhabdomyomas are commonly observed in infants and young children and are often associated with tuberous sclerosis.
Study of diseases and their effects on the body.
Myxoma is typically located in the vicinity of the fossa ovalis in LA. It commonly takes the shape of a pedunculated mass and is made up of spherical myxoma cells and smooth muscle cells embedded in a mucopolysaccharide matrix.
Rhabdomvoma refers to a medical condition. The myocardial mass is grayish in color and extends into the ventricle. It is made up of spider cells, which are polygonal cells containing vacuoles filled with glycogen. These cells are divided by strands of cytoplasm.
Symptoms and signs
Myxoma is a condition that occurs when the function of the mitral valve is compromised by a ball-valve obstruction, leading to symptoms such as difficulty breathing or fainting. It can also cause a stroke if an embolus occurs. A diastolic "tumor plop" can be detected during a physical examination. Other symptoms of Myxoma include fever, weight loss, joint pain, fatigue, heart failure, and anemia.
Rhabdomyoma: Manifests with symptoms indicative of heart chamber blockage.
Therapeutic interventions
Myxoma: Typically non-malignant and can be removed with surgery.
Rhabdomyoma: Frequently undergo spontaneous regression and can therefore be managed conservatively; surgical excision may be necessary in cases of significant blockage or persistent arrhythmias.
Cardiac tumor is most frequently caused by metastasis. Cardiac sarcomas are few, although significant when they manifest. Malignant tumors are neoplasms that frequently undergo metastasis.
Myxomas: The etiology of this condition is still unknown, although around 10% of cases are attributed to an autosomal dominant trait. It is typically observed in adults.
Rhabdomyomas are commonly observed in infants and young children and are often associated with tuberous sclerosis.
Study of diseases and their effects on the body.
Myxoma is typically located in the vicinity of the fossa ovalis in LA. It commonly takes the shape of a pedunculated mass and is made up of spherical myxoma cells and smooth muscle cells embedded in a mucopolysaccharide matrix.
Rhabdomvoma refers to a medical condition. The myocardial mass is grayish in color and extends into the ventricle. It is made up of spider cells, which are polygonal cells containing vacuoles filled with glycogen. These cells are divided by strands of cytoplasm.
Symptoms and signs
Myxoma is a condition that occurs when the function of the mitral valve is compromised by a ball-valve obstruction, leading to symptoms such as difficulty breathing or fainting. It can also cause a stroke if an embolus occurs. A diastolic "tumor plop" can be detected during a physical examination. Other symptoms of Myxoma include fever, weight loss, joint pain, fatigue, heart failure, and anemia.
Rhabdomyoma: Manifests with symptoms indicative of heart chamber blockage.
Therapeutic interventions
Myxoma: Typically non-malignant and can be removed with surgery.
Rhabdomyoma: Frequently undergo spontaneous regression and can therefore be managed conservatively; surgical excision may be necessary in cases of significant blockage or persistent arrhythmias.
Cardiac tumor is most frequently caused by metastasis. Cardiac sarcomas are few, although significant when they manifest. Malignant tumors are neoplasms that frequently undergo metastasis.
- Published on
Pathology - Mitral Regurgitation
Mitral regurgitation is a medical condition characterized by the backflow of blood from the left ventricle into the left atrium of the heart due to a malfunctioning mit
Possible causes encompass rheumatic heart disease, mitral valve prolapse, infective endocarditis, papillary muscle injury following myocardial infarction, and left ventricular dilatation.
Pathophysiology: Occurs due to the abnormal alignment of the mitral valve and/or papillary muscles.
The patient has a holosystolic, high-pitched, blowing murmur that is most audible at the apex and may radiate to the axilla. Additionally, an S3 sound may be detected. In acute instances, individuals may exhibit symptoms of pulmonary edema, however in chronic occurrences, individuals may experience weariness and weakness with physical effort.
Possible complications are pulmonary hypertension and right ventricular failure.
Administer endocarditis prophylaxis and consider mitral valve replacement or repair in the presence of symptoms or indications of left ventricular dysfunction or dilatation.
Mitral valve prolapse is the prevailing cardiac valve abnormality observed in young women, characterized by a murmur occurring during the late systolic phase accompanied by a midsystolic click. Pathologically, there is a condition where the mitral leaflet becomes larger and protrudes into the left atrium during the contraction phase of the heart. Additionally, there is annular dilatation, the thinning of chordae tendineae, and the fibrous thickening of valve leaflets. Typically, it is harmless, however it can be linked to connective tissue disorders such as Marfan Syndrome.
Mitral regurgitation is a medical condition characterized by the backflow of blood from the left ventricle into the left atrium of the heart due to a malfunctioning mit
Possible causes encompass rheumatic heart disease, mitral valve prolapse, infective endocarditis, papillary muscle injury following myocardial infarction, and left ventricular dilatation.
Pathophysiology: Occurs due to the abnormal alignment of the mitral valve and/or papillary muscles.
The patient has a holosystolic, high-pitched, blowing murmur that is most audible at the apex and may radiate to the axilla. Additionally, an S3 sound may be detected. In acute instances, individuals may exhibit symptoms of pulmonary edema, however in chronic occurrences, individuals may experience weariness and weakness with physical effort.
Possible complications are pulmonary hypertension and right ventricular failure.
Administer endocarditis prophylaxis and consider mitral valve replacement or repair in the presence of symptoms or indications of left ventricular dysfunction or dilatation.
Mitral valve prolapse is the prevailing cardiac valve abnormality observed in young women, characterized by a murmur occurring during the late systolic phase accompanied by a midsystolic click. Pathologically, there is a condition where the mitral leaflet becomes larger and protrudes into the left atrium during the contraction phase of the heart. Additionally, there is annular dilatation, the thinning of chordae tendineae, and the fibrous thickening of valve leaflets. Typically, it is harmless, however it can be linked to connective tissue disorders such as Marfan Syndrome.
- Published on
Pathology - Aortic Stenosis
Aortic stenosis is a medical condition characterized by the narrowing of the aortic valve, which obstructs the flow of blood from the heart to the rest of the body.
The causes of aortic stenosis include senile/degenerative calcific aortic stenosis (which happens in persons over the age of 60), congenital bicuspid valve, and rheumatic heart disease.
The aortic valve is affected by calcific deposits on its cusps, resulting in calcitic aortic stenosis. This condition involves fibrosis of the cusps and commissural fusion, which is commonly associated with rheumatic heart disease.
Pathophysiology: The narrowing of the aortic valve causes an increased pressure gradient, which in turn leads to an increase in the workload of the left ventricle. This higher workload results in the thickening of the left ventricle and a loss in its ability to relax and expand. Ultimately, left ventricular failure ensues. Angina occurs due to an imbalance between the amount of oxygen supplied to the heart muscle (caused by reduced compliance leading to the compression of blood vessels within the heart muscle) and the increased demand for oxygen caused by increased stress on the left ventricular wall.
Exhibits symptoms of chest pain, fainting, and congestive heart failure.
The physical examination reveals a gentle second heart sound (S2) and a harsh, late-peaking crescendo. The patient has a systolic ejection murmur that decreases in intensity and can be felt in the neck. Additionally, they have weak and delayed carotid pulses, which means that the pulses in their neck are weaker and slower relative to their heart sounds.
Treatment of hypertension; surgical or percutaneous valve replacement for patients with significant aortic stenosis with symptoms or reduced ejection fraction.
Aortic stenosis is a medical condition characterized by the narrowing of the aortic valve, which obstructs the flow of blood from the heart to the rest of the body.
The causes of aortic stenosis include senile/degenerative calcific aortic stenosis (which happens in persons over the age of 60), congenital bicuspid valve, and rheumatic heart disease.
The aortic valve is affected by calcific deposits on its cusps, resulting in calcitic aortic stenosis. This condition involves fibrosis of the cusps and commissural fusion, which is commonly associated with rheumatic heart disease.
Pathophysiology: The narrowing of the aortic valve causes an increased pressure gradient, which in turn leads to an increase in the workload of the left ventricle. This higher workload results in the thickening of the left ventricle and a loss in its ability to relax and expand. Ultimately, left ventricular failure ensues. Angina occurs due to an imbalance between the amount of oxygen supplied to the heart muscle (caused by reduced compliance leading to the compression of blood vessels within the heart muscle) and the increased demand for oxygen caused by increased stress on the left ventricular wall.
Exhibits symptoms of chest pain, fainting, and congestive heart failure.
The physical examination reveals a gentle second heart sound (S2) and a harsh, late-peaking crescendo. The patient has a systolic ejection murmur that decreases in intensity and can be felt in the neck. Additionally, they have weak and delayed carotid pulses, which means that the pulses in their neck are weaker and slower relative to their heart sounds.
Treatment of hypertension; surgical or percutaneous valve replacement for patients with significant aortic stenosis with symptoms or reduced ejection fraction.
- Published on
Pathology - Aortic regurgitation
Rheumatic heart disease is one of the causes. infective endocarditis, dilatation of ascending aorta linked with hypertension and increasing age, Marfan syndrome, syphilitic aortitis, and ankylosing spondylitis
Insufficient valve results in volume overload of L V leading to concomitant LV hypertrophy and dilatation. Volume overload causes an increase in stroke volume, which in turn leads to hyperdynamic pulses and broadened pulse pressure.
Clinical Presentation
Exhibits dyspnea with exertion and experiences shortness of breath
The cardiac examination reveals a gentle, high-pitched, blowing sound during the relaxation phase of the heart's cycle, which gradually decreases in intensity. This sound is most audible at the left sternal border when the patient leans forward. Additionally, the first heart sound is faint. Chronic aortic regurgitation is linked to an increased pulse pressure, a forceful pulse known as water hammer pulse, visible pulsations in the capillaries of the nail beds (Quincke sign), and a back-and-forth murmur across the remoral artery. The Duroziez sign
Complications may arise, such as the occurrence of severe left ventricular failure.
Therapy
Management of hypertension; administration of diuretics for the treatment of heart failure if present; consideration of valve and/or aortic root replacement in patients with severe aortic regurgitation, symptoms, or considerable left ventricular dilatation.
Rheumatic heart disease is one of the causes. infective endocarditis, dilatation of ascending aorta linked with hypertension and increasing age, Marfan syndrome, syphilitic aortitis, and ankylosing spondylitis
Insufficient valve results in volume overload of L V leading to concomitant LV hypertrophy and dilatation. Volume overload causes an increase in stroke volume, which in turn leads to hyperdynamic pulses and broadened pulse pressure.
Clinical Presentation
Exhibits dyspnea with exertion and experiences shortness of breath
The cardiac examination reveals a gentle, high-pitched, blowing sound during the relaxation phase of the heart's cycle, which gradually decreases in intensity. This sound is most audible at the left sternal border when the patient leans forward. Additionally, the first heart sound is faint. Chronic aortic regurgitation is linked to an increased pulse pressure, a forceful pulse known as water hammer pulse, visible pulsations in the capillaries of the nail beds (Quincke sign), and a back-and-forth murmur across the remoral artery. The Duroziez sign
Complications may arise, such as the occurrence of severe left ventricular failure.
Therapy
Management of hypertension; administration of diuretics for the treatment of heart failure if present; consideration of valve and/or aortic root replacement in patients with severe aortic regurgitation, symptoms, or considerable left ventricular dilatation.
- Published on
Pathology - Acute Rheumatic Fever and Rheumatic Heart Disease
Acute rheumatic fever (ARF): Antibodies produced in response to group A Beta-hemolytic streptococci exhibit cross-reactivity with the patient's tissues, typically manifesting in youngsters aged 3-15 years.
Rheumatic heart disease is a condition that occurs as a result of acute rheumatic fever and often manifests 20 or more years after the initial episode.
ARF is characterized by the presence of Aschoff bodies, which are inflammatory foci surrounded by lymphocytes, and Anitschkow cells, which are macrophages that may become multinucleated. These cells cause pancarditis, an inflammation of the heart tissue. Additionally, there is a serofibrinous pericardial effusion.
RHD: Mitral stenosis characterized by fish-mouth deformity, which may also impact the aortic valve.
Acute rheumatic fever (ARF) is characterized by the appearance of symptoms 2-3 weeks after streptococcal pharyngitis. The major Jones criteria for diagnosing ARF include carditis (inflammation of the heart), migratory polyarthritis (inflammation of multiple joints that moves from one joint to another), chorea (involuntary movements), erythema marginatum (a rash that is pale in the center and has a ring-shaped appearance), and subcutaneous nodules (lumps under the skin). The minor Jones criteria include fever, arthralgia (joint pain), or evidence of a previous streptococcal infection (positive ASO titer).
Laboratory results: Increased erythrocyte sedimentation rate (ESR).
RHD: Manifests with valvular heart disease, typically mitral stenosis, but may also involve aortic stenosis. Valvular disease can result in cardiac hypertrophy, arrhythmias, and heart failure.
Penicillin is used to treat streptococcal infections, while salicylates are used to alleviate fever and arthritis.
RHD: Administer endocarditis prophylaxis if necessary; consider valve replacement for severe, symptomatic valvular disease.
Acute rheumatic fever (ARF): Antibodies produced in response to group A Beta-hemolytic streptococci exhibit cross-reactivity with the patient's tissues, typically manifesting in youngsters aged 3-15 years.
Rheumatic heart disease is a condition that occurs as a result of acute rheumatic fever and often manifests 20 or more years after the initial episode.
ARF is characterized by the presence of Aschoff bodies, which are inflammatory foci surrounded by lymphocytes, and Anitschkow cells, which are macrophages that may become multinucleated. These cells cause pancarditis, an inflammation of the heart tissue. Additionally, there is a serofibrinous pericardial effusion.
RHD: Mitral stenosis characterized by fish-mouth deformity, which may also impact the aortic valve.
Acute rheumatic fever (ARF) is characterized by the appearance of symptoms 2-3 weeks after streptococcal pharyngitis. The major Jones criteria for diagnosing ARF include carditis (inflammation of the heart), migratory polyarthritis (inflammation of multiple joints that moves from one joint to another), chorea (involuntary movements), erythema marginatum (a rash that is pale in the center and has a ring-shaped appearance), and subcutaneous nodules (lumps under the skin). The minor Jones criteria include fever, arthralgia (joint pain), or evidence of a previous streptococcal infection (positive ASO titer).
Laboratory results: Increased erythrocyte sedimentation rate (ESR).
RHD: Manifests with valvular heart disease, typically mitral stenosis, but may also involve aortic stenosis. Valvular disease can result in cardiac hypertrophy, arrhythmias, and heart failure.
Penicillin is used to treat streptococcal infections, while salicylates are used to alleviate fever and arthritis.
RHD: Administer endocarditis prophylaxis if necessary; consider valve replacement for severe, symptomatic valvular disease.
- Published on
Pathology - Acute and Subacute Endocarditis
The causes of acute and subacute endocarditis
Acute: Frequently triggered by Staphylococcus aureus.
Subacute infections are frequently attributed to viridans streptococci, such as Streptococcus mutans. These infections commonly manifest following dental operations.
Study of the nature and causes of diseases.
Acute: The presence of sizable masses made up of fibrin, inflammatory cells, and bacteria on valves that were previously normal.
Subacute refers to the presence of small vegetations on defective valves, which are composed of fibrin, chronic inflammatory cells, and fibrosis.
Symptoms and signs
Acute: Abrupt elevation in body temperature accompanied by shivering: recent appearance of abnormal heart sound
Subacute: Characterized by a gradual and subtle beginning accompanied by a mild elevation in body temperature.
Both types of presentations may include Osler nodes (painful nodules on the pads of the fingers or toes), Janeway lesions (red rash on the palms of the hands and soles of the feet), Roth spots (white patches on the retina with surrounding bleeding), nail-bed splinter hemorrhages, and bacteremia.
Possible complications including chordae tendinee rupture, valvular leaflet perforation, heart failure, suppurative pericarditis, mycotic aneurysms, and septic emboli to the lung, spleen, kidney, heart, or brain.
Treatment for acute cases typically involves the use of broad-spectrum antibiotics, and in severe cases, surgical intervention may be necessary.
Subacute: Administer broad-spectrum antibiotics for treatment. Use antibiotics as a preventive measure against bacterial endocarditis in persons who are susceptible before undergoing dental treatments.
Tricuspid valve endocarditis is linked to intravenous drug usage.
Nonbacterial endocarditis is linked to sterile emboli and is observed in cases of cancer metastasis or renal failure (known as marantic endocarditis), SLE (referred to as Libman-Sacks endocarditis, characterized by the presence of vegetation on both sides of the valve), DIC, or carcinoid disease.
The causes of acute and subacute endocarditis
Acute: Frequently triggered by Staphylococcus aureus.
Subacute infections are frequently attributed to viridans streptococci, such as Streptococcus mutans. These infections commonly manifest following dental operations.
Study of the nature and causes of diseases.
Acute: The presence of sizable masses made up of fibrin, inflammatory cells, and bacteria on valves that were previously normal.
Subacute refers to the presence of small vegetations on defective valves, which are composed of fibrin, chronic inflammatory cells, and fibrosis.
Symptoms and signs
Acute: Abrupt elevation in body temperature accompanied by shivering: recent appearance of abnormal heart sound
Subacute: Characterized by a gradual and subtle beginning accompanied by a mild elevation in body temperature.
Both types of presentations may include Osler nodes (painful nodules on the pads of the fingers or toes), Janeway lesions (red rash on the palms of the hands and soles of the feet), Roth spots (white patches on the retina with surrounding bleeding), nail-bed splinter hemorrhages, and bacteremia.
Possible complications including chordae tendinee rupture, valvular leaflet perforation, heart failure, suppurative pericarditis, mycotic aneurysms, and septic emboli to the lung, spleen, kidney, heart, or brain.
Treatment for acute cases typically involves the use of broad-spectrum antibiotics, and in severe cases, surgical intervention may be necessary.
Subacute: Administer broad-spectrum antibiotics for treatment. Use antibiotics as a preventive measure against bacterial endocarditis in persons who are susceptible before undergoing dental treatments.
Tricuspid valve endocarditis is linked to intravenous drug usage.
Nonbacterial endocarditis is linked to sterile emboli and is observed in cases of cancer metastasis or renal failure (known as marantic endocarditis), SLE (referred to as Libman-Sacks endocarditis, characterized by the presence of vegetation on both sides of the valve), DIC, or carcinoid disease.
- Published on
Pathology - Myocarditis
Myocarditis is an inflammation of the heart muscle.
Typically attributed to viral agents, such as Coxsackievirus A and Coxsackievirus B. Additional factors contributing to the condition include Trypanosoma cruzi (Chagas disease), fungi such as candida, helminthes like trichinosis, parasites such as toxoplasmosis, bacteria including Lyme disease, postviral syndrome, HIV, SLE, medication hypersensitivity, hyper- or hypothyroidism, and sarcoidosis.
Pathology: Macroscopic examination reveals obvious hemorrhages on the ventricular myocardium. Microscopic examination shows widespread myocardial degeneration and necrosis, accompanied by an infiltration of mononuclear inflammatory cells.
Presenting Symptoms
Can either have no symptoms or manifest as biventricular heart failure. The patient may also have pyrexia, dyspnea, asthenia, palpitations, or pleuropericardial discomfort.
Possible complications encompass arrhythmias or abrupt fatality.
Therapy
Treatment typically involves the administration of diuretics, B-blockers, vasodilators, or ionotropes as necessary. If a specific infectious agent is discovered, it may be necessary to administer antibiotic treatment targeted against the infection.
Myocarditis is an inflammation of the heart muscle.
Typically attributed to viral agents, such as Coxsackievirus A and Coxsackievirus B. Additional factors contributing to the condition include Trypanosoma cruzi (Chagas disease), fungi such as candida, helminthes like trichinosis, parasites such as toxoplasmosis, bacteria including Lyme disease, postviral syndrome, HIV, SLE, medication hypersensitivity, hyper- or hypothyroidism, and sarcoidosis.
Pathology: Macroscopic examination reveals obvious hemorrhages on the ventricular myocardium. Microscopic examination shows widespread myocardial degeneration and necrosis, accompanied by an infiltration of mononuclear inflammatory cells.
Presenting Symptoms
Can either have no symptoms or manifest as biventricular heart failure. The patient may also have pyrexia, dyspnea, asthenia, palpitations, or pleuropericardial discomfort.
Possible complications encompass arrhythmias or abrupt fatality.
Therapy
Treatment typically involves the administration of diuretics, B-blockers, vasodilators, or ionotropes as necessary. If a specific infectious agent is discovered, it may be necessary to administer antibiotic treatment targeted against the infection.
- Published on
Pathology - Dilated Cardiomyopathy
Dilated cardiomyopathy is a medical condition characterized by the enlargement and weakening of the heart muscle, leading to reduced pumping ability and potential heart failure.
The most prevalent form of cardiomyopathy, accounting for 90% of cases, can either be idiopathic or have secondary causes such as alcoholism, chronic ischemia, wet beriberi (caused by vitamin B deficiency), or postmyocarditis. Substance misuse of cocaine, harmful effects of doxorubicin, heart muscle disease during pregnancy, and genetic disorders affecting muscles
The chambers of the heart are enlarged, the muscle cells have become hypertrophic, and there is an increase in fibrous tissue between the cells. These changes lead to a decrease in the heart's ability to contract effectively, known as systolic dysfunction.
Indications of congestive heart failure include difficulty breathing (dyspnea), difficulty breathing while lying down (orthopnea), edema in the lower extremities, and reduced ability to exercise.
Imaging: The chest X-ray reveals an enlarged heart. The echocardiography reveals enlarged chambers and reduced contractile ability.
Management of the primary condition if possible; Administration of ACE inhibitors; Utilization of beta-blockers; Prescription of diuretics; Consideration of implantation of an implantable cardioverter-defibrillator (ICD) if ejection fraction (EF) is less than 35%; Contemplation of transplantation for severe instances
Dilated cardiomyopathy is a medical condition characterized by the enlargement and weakening of the heart muscle, leading to reduced pumping ability and potential heart failure.
The most prevalent form of cardiomyopathy, accounting for 90% of cases, can either be idiopathic or have secondary causes such as alcoholism, chronic ischemia, wet beriberi (caused by vitamin B deficiency), or postmyocarditis. Substance misuse of cocaine, harmful effects of doxorubicin, heart muscle disease during pregnancy, and genetic disorders affecting muscles
The chambers of the heart are enlarged, the muscle cells have become hypertrophic, and there is an increase in fibrous tissue between the cells. These changes lead to a decrease in the heart's ability to contract effectively, known as systolic dysfunction.
Indications of congestive heart failure include difficulty breathing (dyspnea), difficulty breathing while lying down (orthopnea), edema in the lower extremities, and reduced ability to exercise.
Imaging: The chest X-ray reveals an enlarged heart. The echocardiography reveals enlarged chambers and reduced contractile ability.
Management of the primary condition if possible; Administration of ACE inhibitors; Utilization of beta-blockers; Prescription of diuretics; Consideration of implantation of an implantable cardioverter-defibrillator (ICD) if ejection fraction (EF) is less than 35%; Contemplation of transplantation for severe instances
- Published on
Pathology - Hypertrophic Obstructive Cardiomyopathy
The cause of Hypertrophic Obstructive Cardiomyopathy :
The condition is either idiopathic or caused by a mutation in the D-myosin heavy-chain gene that is inherited in an autosomal dominant manner.
Pathology: Enlargement of the interventricular septum and myocardium; the left ventricle has a curved form resembling a banana; disorganized organization of enlarged heart muscle cells.
The pathophysiology involves an uneven enlargement of the interventricular septum, causing a dynamic obstruction in the left ventricular outflow tract and reduced filling during diastole, ultimately resulting to a decrease in cardiac output.
Patients exhibit symptoms such as difficulty breathing, chest pain, irregular heartbeats, or fainting during physical activity. A minority of patients may experience abrupt fatality.
Imaging: The echocardiogram reveals uneven thickening of the wall between the ventricles, causing a blockage in the flow of blood from the left ventricle and aberrant movement of the mitral valve during contraction.
Beta-blockers should be used to manage the condition. Strenuous exercise should be avoided. It is important to stay well hydrated. individuals with risk factors for sudden cardiac death may consider getting an implantable cardioverter-defibrillator (ICD). First-degree relatives should undergo screening. If symptoms persist despite medicinal therapy, individuals may need to undergo surgical myectomy or septal alcohol ablation.
The cause of Hypertrophic Obstructive Cardiomyopathy :
The condition is either idiopathic or caused by a mutation in the D-myosin heavy-chain gene that is inherited in an autosomal dominant manner.
Pathology: Enlargement of the interventricular septum and myocardium; the left ventricle has a curved form resembling a banana; disorganized organization of enlarged heart muscle cells.
The pathophysiology involves an uneven enlargement of the interventricular septum, causing a dynamic obstruction in the left ventricular outflow tract and reduced filling during diastole, ultimately resulting to a decrease in cardiac output.
Patients exhibit symptoms such as difficulty breathing, chest pain, irregular heartbeats, or fainting during physical activity. A minority of patients may experience abrupt fatality.
Imaging: The echocardiogram reveals uneven thickening of the wall between the ventricles, causing a blockage in the flow of blood from the left ventricle and aberrant movement of the mitral valve during contraction.
Beta-blockers should be used to manage the condition. Strenuous exercise should be avoided. It is important to stay well hydrated. individuals with risk factors for sudden cardiac death may consider getting an implantable cardioverter-defibrillator (ICD). First-degree relatives should undergo screening. If symptoms persist despite medicinal therapy, individuals may need to undergo surgical myectomy or septal alcohol ablation.
